Search Results 291-300 of 8974 for Conduction

1. A Study to Evaluate the Effectiveness and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

   * ECG evidence of acute ischemia or active conduction system abnormalities * Prior treatment with hematopoietic growth factors, transfusions of blood or ...

2. Publications - Nicholas L. Deep, M.D. - Mayo Clinic

   Modifications to Implanting the OSIA(R) 2 Bone Conduction Hearing Implant: How I Do it. Laryngoscope. 2022 Sep; 132 (9):1850-1854 Epub 2022 May 26. View ...

3. Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors - Mayo Clinic

   Significant conduction defects (i.e. second or third degree atrio-ventricular block or sick sinus syndrome). Bradycardia: heart rate < 50 beats per minute ...

4. A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. - Mayo Clinic

   Clinical features include length dependent sensory and motor loss, with sensorimotor axonal or demyelinating changes on a nerve conduction study. Weekly ...

5. Publications - Duy T. Nguyen, M.D. - Mayo Clinic

   ... conduction disease requiring pacemakers. J Interv Card Electrophysiol. 2021 Jun; 61 (1):29-35 Epub 2020 May 26. View PubMed; Kunkel M, Rothstein P, Sauer P ...

6. Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer - Mayo Clinic

   conduction abnormality requiring a pacemaker;; valvular disease with documented compromise in cardiac function;; symptomatic pericarditis.;; history of cardiac ...

7. Discovery's Edge: Beat still my beating heart - Mayo Clinic News Network

   Langendorff systems have been used to test the effects of drugs on the heart, electrical conduction, the effect of genetic mutations, and myriad of other ...

8. Development of a PLS-Specific Clinical Rating Scale, Capable of Evaluating the Clinical Functional State of Patients with PLS in Multi-Site Study - Mayo Clinic

   Normal nerve conduction studies and normal needle electrode EMG examination when the diagnosis of PLS was made; Expected to have at least some bulbar ...

9. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients - Mayo Clinic

   Subjects with evidence of intraventricular conduction delay, defined as a QRS interval greater than 110 msec, will be excluded if the QTcF is >500 msec for ...

10. Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations - Mayo Clinic

    No major conduction abnormality (unless a cardiac pacemaker is present). Adequate pulmonary function defined as: No evidence of dyspnea at rest, no exercise ...